Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Non-cash Items (2023 - 2025)

Abeona Therapeutics (ABEO) has 6 years of Non-cash Items data on record, last reported at $174792.0 in Q3 2025.

  • For Q3 2025, Non-cash Items rose 11.31% year-over-year to $174792.0; the TTM value through Sep 2025 reached $174792.0, up 11.31%, while the annual FY2024 figure was $6000.0, 95.56% down from the prior year.
  • Non-cash Items reached $174792.0 in Q3 2025 per ABEO's latest filing, up from $6000.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $174792.0 in Q3 2025 and bottomed at $3000.0 in Q4 2023.
  • Average Non-cash Items over 3 years is $64425.1, with a median of $10000.0 recorded in 2024.
  • Peak YoY movement for Non-cash Items: surged 100.0% in 2024, then tumbled 96.04% in 2025.
  • A 3-year view of Non-cash Items shows it stood at $3000.0 in 2023, then soared by 100.0% to $6000.0 in 2024, then soared by 2813.2% to $174792.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Non-cash Items were $174792.0 in Q3 2025, $6000.0 in Q2 2025, and $3000.0 in Q1 2025.